Evidence map›Paper›PMID 32901020›Full record

ArticleNature communications2020

Author Correction: mTORC2-AKT signaling to ATP-citrate lyase drives brown adipogenesis and de novo lipogenesis.

C Martinez Calejman, S Trefely, S W Entwisle, A Luciano, S M Jung, W Hsiao, A Torres, C M Hung, H Li, N W Snyder and 3 more

Open access · goldAbstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Nature communications, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.4field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 1 country.

C Martinez CalejmanProgram in Molecular Medicine, University of Massachusetts Medical School, Worcester, MA, 01605, USA.
S TrefelyDepartment of Cancer Biology, University of Pennsylvania, Philadelphia, PA, 19104, USA.
S W EntwisleDepartment of Genome Sciences, University of Washington, Seattle, WA, 98195, USA.
A LucianoProgram in Molecular Medicine, University of Massachusetts Medical School, Worcester, MA, 01605, USA.ORCID http://orcid.org/0000-0002-4178-3422
S M JungProgram in Molecular Medicine, University of Massachusetts Medical School, Worcester, MA, 01605, USA.
W HsiaoProgram in Molecular Medicine, University of Massachusetts Medical School, Worcester, MA, 01605, USA.
A TorresDepartment of Cancer Biology, University of Pennsylvania, Philadelphia, PA, 19104, USA.
C M HungProgram in Molecular Medicine, University of Massachusetts Medical School, Worcester, MA, 01605, USA.
H LiProgram in Molecular Medicine, University of Massachusetts Medical School, Worcester, MA, 01605, USA.
N W SnyderAJ Drexel Autism Institute, Drexel University, Philadelphia, PA, 19104, USA.ORCID http://orcid.org/0000-0001-5643-8747
J VillénDepartment of Genome Sciences, University of Washington, Seattle, WA, 98195, USA.ORCID http://orcid.org/0000-0002-1005-1739
K E WellenDepartment of Cancer Biology, University of Pennsylvania, Philadelphia, PA, 19104, USA.ORCID http://orcid.org/0000-0002-2281-0042
D A GuertinProgram in Molecular Medicine, University of Massachusetts Medical School, Worcester, MA, 01605, USA. david.guertin@umassmed.edu.
University of Massachusetts Chan Medical School · USCancer Research Institute · USUniversity of Washington · USDrexel University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

An amendment to this paper has been published and can be accessed via a link at the top of the paper.

Identifiers

PMID32901020
PMCPMC7479589
OpenAlexW3084328942

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.